Biosergen AB (OSTO:BIOSGN) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BIOSGN Biosergen AB OSTO:BIOSGN
18 GF Score
Price kr6.00
View Full Analysis

What is Biosergen AB FCF Margin %?

Biosergen AB OSTO:BIOSGN 18 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates OSTO:BIOSGN with a GF Score™ of 18/100. Among 952 Biotechnology companies, Biosergen AB ranks worse than 105041.91% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biosergen AB's Free Cash Flow for the three months ended in Dec. 2025 was kr-7.75 Mil. Biosergen AB's Revenue for the three months ended in Dec. 2025 was kr0.00 Mil. Therefore, Biosergen AB's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Biosergen AB's current FCF Yield % is -252.21%.

The historical rank and industry rank for Biosergen AB's FCF Margin % or its related term are showing as below:


OSTO:BIOSGN's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

Biosergen AB FCF Margin % Related Terms

Biosergen AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Biosergen AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosergen AB FCF Margin % Chart

Biosergen AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biosergen AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:BIOSGN vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, Biosergen AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosergen AB FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biosergen AB's FCF Margin % falls into.


OSTO:BIOSGN
18GF Score
Biosergen AB OSTO:BIOSGN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosergen AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biosergen AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-36.811/0
= %

Biosergen AB's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-7.747/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Biosergen AB (OSTO:BIOSGN) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biosergen AB and its competitors. According to the industry distribution chart, Biosergen AB ranks #999999 out of 952 companies in the Biotechnology industry.
Is Biosergen AB's FCF Margin % too high?
Biosergen AB's current FCF Margin % is 0.00%. Based on the distribution chart, Biosergen AB ranks #999999 out of 952 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Biosergen AB has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Biosergen AB's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Biosergen AB ranks #999999 out of 952 companies for FCF Margin %. This places Biosergen AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biosergen AB and its competitors. Biosergen AB's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosergen AB stock overvalued right now?
Biosergen AB (OSTO:BIOSGN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Biosergen AB's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Biosergen AB (OSTO:BIOSGN), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosergen AB Business Description

Address Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a clinical stage biotechnology company advancing the treatment of life-threatening fungal infections. Biosergen' s mission is to develop the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 potential is to eliminate fungal infections rather than just slowing their growth, reducing the risk of resistance.
18GF Score

Get the complete analysis for OSTO:BIOSGN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.00
Price